ORMP
Oramed Pharmaceuticals Inc
4.70$
+1.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -225.3% | – | – | – | – | – | – | – | – | |
| – | -33.3% | +0.0% | +25.0% | +20.0% | +33.3% | -12.5% | +1,000.0% | -24.7% | +237.9% | -1.5% | -37.3% | |
| – | -8.2% | -52.9% | +148.4% | -1.8% | -47.8% | -42.5% | +479.6% | +327.1% | -63.4% | -3.8% | +47.8% | |
| – | +435.4% | +1,645.1% | -80.9% | -225.4% | – | -1,189.0% | – | – | – | – | -159.6% | |
| – | -92.9% | +800.0% | -22.2% | -28.6% | +200.0% | +446.7% | +357.3% | +32.3% | -48.8% | -92.9% | +10,639.5% | |
| – | -74.7% | +383.4% | – | -262.8% | – | -58.9% | -581.3% | – | -341.8% | – | -94.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +90.9% | |
| – | – | – | – | – | – | – | – | – | – | -200.0% | -100.0% | |
| – | -41.6% | +23.9% | -86.8% | +1,328.4% | – | – | +326.3% | -88.6% | +349.6% | -200.1% | -90.9% | |
| – | – | -52.2% | -91.1% | +1,530.6% | -264.9% | – | +262.9% | -163.5% | – | – | -118.7% | |
| – | – | – | -225.7% | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.